An extracellular matrix-related prognostic and predictive indicator for early-stage non-small cell lung cancer

Abstract

Prognosis and prediction of adjuvant chemotherapy response in non-small cell lung cancer can have significant clinical impact. Here, the authors show that differential expression of a 29 extracellular matrix gene indicator, EPPI, can predict patient outcome.